Roberts Rimsa

Roberts Rimsa has a strong background in microfluidic chip development and fabrication. Roberts started their career as an Undergraduate Research Assistant at Riga Technical University, where they studied the effect of crystal defect migration in Ge after laser radiation. Roberts then continued their research at the University of Leeds as a PhD Researcher, focusing on the development of microfluidic chips for medical diagnostics and gaining expertise in electromechanical design and fluid dynamics.

After completing their PhD, Roberts joined QuantuMDx Group Limited as a Microfluidics Engineer, where they were responsible for designing and developing disposable microfluidic cartridges and sample collection devices for diagnostic tests. Roberts also served as the technical lead in three work packages related to the development of the microfluidic disposable.

Following their time at QuantuMDx, Roberts joined the Institute of Solid State Physics at the University of Latvia as a Leading Researcher. Here, they worked on microfluidic project development, particularly focusing on organ-on-chip device concept design and fabrication using mass-manufacturable techniques. Roberts played a key role in attracting significant funding to the institution during their tenure.

Currently, Roberts is the CTO and Co-founder of Cellbox Labs. In this role, they lead a team in the development of microfluidic chips and complementary instruments for the production of miniature human organ replicas. These replicas are used by pharmaceutical companies for preclinical tests in human-like organs.

Roberts Rimsa received their education from the University of Leeds. Roberts obtained a Bachelor of Science (BSc) in Nanotechnology from 2010 to 2013. Subsequently, they pursued a Doctor of Philosophy (PhD) from 2013 to 2017, specializing in Molecular Scale Engineering as part of the Centre for Doctoral Training. In addition, they hold a CIEH Level 2 Health and Safety Certificate from The Chartered Institute of Environmental Health, which they obtained in September 2014.